Opinion
Genetically modified foods: let the science speak
Genetically modified food has become a highly politicised, emotional issue with heated arguments and accusations between those for and against their use.
Kerry Gordon
Opinion | 6 November 2013
Was South Africa sold out in 1994?
Ronnie Kasrils argued in the Guardian in June that the ANC in 1994 accepted a "devil's pact ... " that tied South Africa's economy "to the neoliberal global formula and market fundamentalism ...". Here Rob Petersen explains why he thinks Kasrils is mistaken. This is the text of a speech given at an Equal Education event on 31 October.
Rob Petersen
Opinion | 6 November 2013
Ambrosini is wrong about cancer
Receiving a terminal cancer diagnosis in your early 50s is frightening. It is difficult to imagine what Mario Ambrosini is going through. That he wishes to beat cancer and that he is disappointed with medical science because it offers him so little hope is entirely understandable.
Nathan Geffen, GroundUp Editor
Opinion | 4 November 2013
A still flickering beacon of hope
“South Africa has rather fallen off the radar,” the BBC journalist noted. This was similar to comments voiced by former anti-apartheid activists and by several one-time strugglista exiles, mainly in London, who never returned home to settle. Because, in the mainstream media of Europe, there is little mention of South Africa: and, after six weeks abroad, it was, for me, a useful reminder of how minor is our role in global political and economic affairs.
Terry Bell
Opinion | 28 October 2013
Patents must serve the public interest
It is in the interests of large multinational companies to secure as many patents as possible. The Treatment Action Campaign, in line with the Draft National Policy on Intellectual Property (IP), argues that patents should only be granted for medicines that are truly new and innovative, for example a brand new cancer cure.
Marcus Low
Opinion | 24 October 2013
Patents must serve the public interest
Thousands of people in South Africa have drug-resistant tuberculosis (TB). Many of them will die. Death from TB can be slow and horrible. Many of those who do survive will struggle with severe side effects and may need daily pills and injections. Some, like 23-year old Phumeza who described her experience of TB treatment at a Treatment Action Campaign (TAC) press conference last week, will live, but lose their hearing.
Marcus Low
Opinion | 24 October 2013
How a patent is blocking access to a life-saving TB medicine
Thousands of people in South Africa have drug-resistant tuberculosis (TB). Many of them will die. Death from TB can be slow and horrible. Many of those who do survive will struggle with severe side effects and may need daily pills and injections. Some, like 23-year old Phumeza who described her experience of TB treatment at a Treatment Action Campaign (TAC) press conference last week, will live, but lose their hearing.
Marcus Low
Opinion | 23 October 2013
The strike wave and what it means
The International Monetary Fund (IMF) said last week that if South Africa wants to achieve higher growth and cut unemployment “a social bargain” is needed that would pull together trade unions, business and the government to implement the NDP (National Development Plan). It also suggests that trade unions moderate wage demands and that the State implement its massive infrastructure spending plans. The IMF flagged "escalating labour tensions" as a "key domestic risk".
Jack Lewis
Opinion | 10 October 2013
Khayelitsha residents on the O’Regan/Pikoli Commission
The O'Regan/Pikoli Commision of Inquiry into policing in Khayelitsha is to go ahead after a Constitutional Court ruling last week. GroundUp went to the streets of Khayelitsha to gauge people’s reaction to the ruling.
Nwabisa Pondoyi
Opinion | 9 October 2013